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Abstract 
BACKGROUND: Post-traumatic brain injury fatigue (PTBIF) is a major problem in the years 
after traumatic brain injury (TBI), yet little is known about its persistence and resolution.  
OBJECTIVE: To identify factors related to PTBIF remission and resolution. METHODS: TBI 
Model System registrants at 5 centers who participated in interviews at either 1 and 2 years post-
injury (Y1-2 Cohort), or 2 and 5 years post injury (Y2-5 Cohort). Characteristics of participants 
with PTBIF remission were compared to those with PTBIF persistence. Variables studied 
included the presence of and changes in disability, sleep dysfunction, mood, and community 
participation. RESULTS: Functional independence Measure did not differ significantly between 
groups or over time. In the Y1-2 Cohort the Fatigue Resolved group scored significantly better 
on the Disability Rating Scale and Pittsburgh Sleep Quality Index. In the Y2-5 Cohort the 
Fatigue Resolved group scored significantly higher on a measure of community participation. 
CONCLUSIONS: Less than half of the sample in each cohort experienced a remission of 
PTBIF between time points. Persistence of PTBIF from one to two years post-injury is 
associated with disability, sleep disturbance, and depression while persistence of fatigue beyond 
two years post-injury appears to be related to participation level, underscoring the potential 
impact of effective surveillance, assessment, and treatment of this condition in optimizing life 
after TBI.  Differences in fatigue progression may point to the presence of different types of 
PTBIF. 
 
 
 
 
3  
1.  Introduction 
Fatigue is one of the most common symptoms reported after a traumatic brain injury 
(TBI), affecting between 21% and 73% of individuals with TBI [1, 2].  Symptoms of post-TBI 
fatigue (PTBIF) can present soon after injury and become chronic. Van der Naalt and colleagues 
(1999) noted that at 1 month post injury, 57% of the sample reported fatigue, dropping to 45% at 
6 months and one year [1]. Another study reported that  73% of individuals continue to 
experience fatigue as a chronic problem 5 years post-injury [3].  
Cantor and colleagues (2013, p. 876) noted that PTBIF is “often associated with a felt 
sense of disproportionate exertion and associated mental or physical exhaustion and inability to 
perform”.  PTBIF is a central fatigue condition, resulting from a neurologic insult to the brain 
and different from peripheral fatigue, which describes muscle and physical limitations [4].  Other 
neurologic conditions such as stroke, multiple sclerosis, Parkinson’s disease, and fibromyalgia 
have central fatigue as a common symptom.   
Fatigue is often rated as the worst symptom experienced after a TBI [5, 6].  Individuals 
with PTBIF tend to report higher levels of disability and lower satisfaction with life than 
individuals with TBI without fatigue complaints [7, 8].  In fact, studies have shown that the 
presence of PTBIF may prevent return to work [9]. PTBIF has not been found to be associated 
with age or injury severity [3, 10]. 
Although fatigue after TBI has been associated with other conditions or symptoms, such 
as depression, anxiety, pain, and sleep disturbance [11], studies suggest that PTBIF can present 
as  a distinct condition [7, 12]. While multiple studies have evaluated PTBIF characteristics and 
correlates, longitudinal studies specifically looking at the resolution of PTBIF are scarce.  The 
current study compared patients with resolution of PTBIF to those who continued to have 
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symptoms over time in order to add to the literature using longitudinal data to better understand 
factors that may be associated with PTBIF remission. Although mere associations may not 
indicate causality, they are important to identify in order to direct future research to determine 
which factors are causal or have mediating or moderating properties. In this way, a more solid 
foundation is formed upon which treatment interventions can be developed and tested for 
efficacy.   
 
2.  Methods 
2.1. Participants 
Participants were recruited from individuals already enrolled in the National Institute on 
Disability, Independent Living, and Rehabilitation Research (NIDILRR) TBI Model Systems 
program (TBIMS) National Database (NDB). The TBIMS NDB is a prospective longitudinal 
multicenter study that collects data about the demographics, injury characteristics, and outcomes 
of individuals with TBI who have received inpatient rehabilitation at TBIMS sites. Criteria for 
inclusion in the TBIMS NDB study include:  
(1) Presence of TBI of at least moderate severity (as defined by posttraumatic amnesia at least 24 
hours, trauma-related intracranial neuroimaging abnormalities, or loss of consciousness with a 
duration of more than 30 minutes);  
(2) Glasgow Coma Scale score of less than 13 upon admission to the emergency department; 
(3) Age 16 or older at the time of injury;  
(4) Admission to a TBIMS trauma hospital no later than 72 hours after injury;  
(5) Participation in comprehensive rehabilitation at a TBIMS brain injury inpatient 
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rehabilitation program (inpatient rehabilitation facility or rehabilitation hospital unit, skilled 
nursing facility, or long-term acute care hospital); 
(6) Informed consent provided by the patient, or family/legal guardian if patient did not have 
capacity.  
Participants who were able to take part in the TBIMS follow-up interviews typically 
conducted at 1, 2, and 5 years post-injury were recruited for the current study from five 
collaborating TBIMS centers: Mount Sinai Medical Center in New York, NY; Santa Clara 
Valley Medical Center in San Jose, CA; Kessler Foundation in West Orange, NJ; Carolinas 
Rehabilitation in Charlotte, NC; and JFK Johnson Rehabilitation Institute in Edison, NJ. Data 
collection took place between 2007 and 2012. In addition to the above inclusion criteria, only 
individuals with TBI who were able to complete the follow-up interviews independently were 
enrolled into the current study. For feasibility reasons, certain centers collected data at years 1 
and 2 post injury and others at years 2 and 5 (See Cantor et al., 2012)[7]. There were a total of 
237 participants with complete data at two time points. For the purposes of the current 
investigation examining factors associated with the remission of PTBIF, only individuals with 
complete data at two time points who had PTBIF at T1 were included (N=79).  
2.2. Measures 
2.2.1. Outcome Measures 
The Functional Independence Measure™ (FIM) is an index of motor and cognitive 
ability [13] and consists of 18 items with a Likert-type rating scale ranging from need for total 
assistance (1) to complete independence (7). Items can be divided into motor and cognitive 
domains. The FIM has been shown to have good internal consistency (Cronbach’s α between .86 
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and .97) with TBI populations and to be sensitive to changes in functional ability from admission 
to discharge and follow-up [14-17].  
The Disability Rating Scale (DRS) is used to examine functional recovery of individuals 
with TBI during and after rehabilitation [18, 19]. The DRS consists of eight items addressing 
three categories identified by the World Health Organization (WHO) as components of 
disablement: impairment, disability, and handicap. It has been shown to be a valid measure of 
disablement with good inter-rater reliability and test-retest reliability [20, 21]. Scores range from 
0 (no disablement) to 29 (maximum disablement). 
The Patient Health Questionnaire (PHQ-9) [22] is a screening tool for depression 
consisting of 9 items derived from the PRIME-MD, a broader, multi-disorder health 
questionnaire [23]. The PHQ-9 has good test-retest reliability (r = .84) and excellent internal 
consistency (α = .86-.89) [22].  The PHQ-9 has good criterion and construct validity, and good 
test-retest reliability in individuals with TBI [24]. 
The Satisfaction with Life Scale (SWLS) is a five-item self-report measure of global life 
satisfaction [25, 26]. The SWLS has shown to be valid and reliable and has been used in a wide 
range of age groups and applications [26]. It has convergent validity with other scales and 
assessments of subjective well-being as well as discriminant validity from measures of emotional 
well-being [25, 27]. The SWLS also has high internal consistency and high temporal stability 
[25]. Additionally, the SWLS has been shown to be sensitive to changes in life satisfaction 
following clinical interventions [27]. 
The Participation Assessment with Recombined Tools (PART-O; [28] is a 24-item self-
report measure of community integration following a TBI that was developed using items from 
other existing instruments measuring participation. Subjects are asked to reflect on a specific 
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timeframe and respond to questions on their typical level of societal participation and the close 
relationships they have (social supports, household activities and their social and community 
integration). The scale has been in use as part of the TBIMS follow up interview since 2007. 
PART–O subscales (Productivity, Social Relations, and Out and About in the Community) allow 
for the characterization of how one participates [28].  The measure has been shown to have good 
construct and concurrent validity and item reliability, allowing one to reliably measure 
meaningful differences among people with varying levels of participation [29]. 
The Pittsburgh Sleep Quality Index (PSQI) is a validated measure that uses 9 items to 
examine sleep quality and disturbances of sleep and to assesses insomnia symptoms, including 
difficulty initiating sleep or maintaining sleep, as well as their frequency and duration, and 
factors that may affect sleep (e.g., pain, medications) [30].  Scores exceeding 5 are indicative of 
a sleep disorder [31].  The PSQI has been shown to be sensitive to sleep disturbances after TBI 
[32].  
2.2.2. Measurement of Fatigue 
Multidimensional Assessment of Fatigue (MAF) [33] is a self-report measure 
operationalizing four domains of fatigue: severity, distress, impact on activity, and timing. The 
first 15 questions on this measure are used to calculate a Global Fatigue Index (GFI), with scores 
that range from 0 to 50. The higher the score, the greater the individual’s fatigue, with 
individuals reporting no fatigue were assigned a score of 0. Englander and colleagues [34] used 
scores of 27 and above as an abnormal amount of fatigue after brain injury, although average 
fatigue scores for TBI samples have been reported as high as 24.4, SD=11.7, and 28.4, SD=11.3 
[8, 35]. The current study used GFI scores over 21 to indicate PTBIF based on Cantor et al. 
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(2008), and used a 5-point difference to indicate a minimal clinically important difference based 
on data derived from previous studies [36, 37].  
2.3. Data Analysis 
2.3.1. Descriptive Statistics 
Data were collected on two separate cohorts. The Y1-2 Cohort was surveyed at one and 
two years post-injury (N=47) and the Y2-5 Cohort was surveyed at two and five years post-
injury (N=32). A chi-square analysis showed no significant differences between cohorts on 
demographics and injury characteristics shown in Table 1. One-way Analysis of Variance 
(ANOVA) showed no significant differences between the cohorts on age, education, and 
hospitalization variables shown in Table 2.  
 
PLACE TABLE 1 ABOUT HERE 
 
PLACE TABLE 2 ABOUT HERE 
 
2.3.2.  Determination of Post TBI Fatigue and its remission. 
Two Fatigue Change groups were created. Individuals who had PTBIF at both time 
points were designated as the Fatigue Unresolved group (FU), and those who had PTBIF at T1 
but not at T2 and had achieved the minimal clinically important difference on the GFI as 
described earlier were designated as the Fatigue Resolved group (FR). FR for 30% of the Y1-2 
Cohort and for 44% of the Y2-5 Cohort. There were no significant differences between cohorts 
in terms of percentage of individuals who experienced resolution of PTBIF (χ² = 1.6, df = 1, p = 
9  
0.203). The analyses examining outcome variables were run separately for each of the two 
cohorts. 
2.3.3.  Analysis to examine outcome variables associated with remission of PTBIF 
Group differences were examined over time using a mixed 2 (Fatigue Change group) x 2 
(follow-up time point) Analysis of Variance (ANOVA). Where a significant main effect was 
observed, planned comparisons were conducted to further examine the effect. Bonferroni 
correction for multiple comparisons was used where appropriate. 
3.  Results 
3.1.  Descriptives of GFI in the FR and FU groups.  
Y1-2 Cohort: The FU group had GFI scores ranging from 21 to 44 at T1 and 22 to 48 at 
T2. The FR group had GFI scores ranging from 21 to 46 at T1 and 0 to 21 at T2. At T1 the mean 
GFI values for the FU (M = 31.9, SD = 7.2) and FR groups (M = 30.7, SD = 7.7) showed no 
significant difference, F(1,45) = 0.3, p = 0.601. 
Y2-5 Cohort: The FU group had GFI scores ranging from 21 to 46 at T1 and 23 to 50 at 
T2. The FR group had GFI scores ranging from 22 to 39 at T1 and 0 to 22 at T2. At T1 the mean 
GFI values for the FU (M = 31.3, SD = 8.1) and FR groups (M = 33.4, SD = 8.7) showed no 
significant difference, F(1,30) = 2.5, p = 0.124. 
3.2.  Functional Independence and Level of Disability  
Neither of the two cohorts showed any significant differences on FIM scores between FR 
and FU groups. However, the Y1-2 Cohort showed a significant main group effect on the DRS, 
with significantly higher scores (indicating increased disability) for the FU group F(1,45) = 4.3, 
p = 0.043. Group comparisons with Bonferroni correction at each time point showed no 
significant difference in DRS scores between groups at T1, F(1,45) = 1.8, p = 0.181. At T2, 
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however, a significant difference was observed after a noticeable divergence from one to two 
years post injury, F(1,45) = 6.2, p = 0.016. No significant differences in DRS were found for the 
Y2-5 Cohort. See Figure 1. 
PLACE FIGURE 1 ABOUT HERE 
3.3.  Sleep Quality 
For the Y1-2 Cohort, there was a significant main effect for Time, F(1,45) = 6.7, p = 
0.013, and a significant Time x Group interaction, F(1,45) = 7.2, p = 0.010. The FR group 
showed improved sleep quality compared with the FU group, F(1,45) = 8.9, p = 0.005. Group 
comparisons with Bonferroni correction at each time point showed no significant difference in 
sleep quality between groups at T1, F(1,45) = 1.9, p = 0.179, followed by a significant difference 
at T2, F(1,45) = 19.6, p < 0.001, after a noticeable decrease in PSQI (i.e., improved sleep 
quality). See Figure 2. 
For the Y2-5 Cohort, there were no significant differences between fatigue resolution 
groups. However, a main effect was found for change over time with both groups showing 
significant improvement in sleep quality from 2 to 5 years post-injury, F(1,26) = 8.0, p = 0.009. 
 
PLACE FIGURE 2 ABOUT HERE 
 
3.4.  Depression and Satisfaction with Life   
In the Y1-2 Cohort, there was a significant between-subjects effect with the FU group 
showing significantly greater levels of depression on the PHQ-9, F(1,46) = 7.1, p = 0.011. There 
was no significant effect between groups at T1 but there was at T2, F(1,45) = 7.6, p = 0.008. See 
Figure 3. 
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PLACE FIGURE 3 ABOUT HERE 
 
With regard to the SWLS, there were no significant differences between groups and no 
significant changes in either group over time. For the Y2-5 Cohort, there were no significant 
differences in PHQ-9 or SWLS between FR and FU groups. 
 
3.5.  Community Participation 
There were no significant effects found between fatigue resolution groups in the Y1-2 
Cohort. In the Y2-5 Cohort, there was a significant between subjects effect showing that the FR 
group tended to have higher PART-O scores than the FU group, F(1,26) = 5.0, p = 0.035. 
 
PLACE FIGURE 4 ABOUT HERE 
4.  Discussion 
The current study examined changes among individuals with TBI in various outcomes, 
including disability, sleep dysfunction, mood, and community participation, as a function of 
post-TBI fatigue. Less than half of the sample indicated a remission of PTBIF between time 
points.  
The lack of significant findings with regard to functional independence (FIM) may be 
due to a ceiling effect in the FIM with both groups being close to the maximum FIM rating at T1 
and having very little room to improve. Disablement ratings (DRS), on the other hand, increased 
slightly over time in the FU group while in the FR group the mean remained stable, resulting in 
significant group differences at T2.  
12  
Previous cross sectional research failed to find any significant relationship between 
PTBIF and participation [8]. In the current analysis, the Y2-5 Cohort showed significantly higher 
participation in the FR group. Yet, neither group showed any change in participation over time. 
In other words, in the FR group, participation was just as high at the initial time point as it was at 
follow up at 5 years post-injury. While this lack of change over time may be consistent with the 
previous findings by Cantor et al. [8], the difference between groups suggest that there may be 
another unmeasured variable to explain why this group difference was found.  
In the Y1-2 Cohort, Sleep quality (PSQI) tended to remain quite stable for the FU group 
while those experiencing a remission of fatigue showed a notable decline in sleep difficulties by 
the second year post-injury. It should be noted that the FR group falls below 5, which on the 
PSQI would be classified as not having significant sleep disturbance. The Y2-5 Cohort began 
with PSQI values comparable to the FU group of the Y1-2 Cohort and showed no significant 
group differences. All those with PTBIF at 2 years post-injury in this group represented a more 
chronic phase after TBI where PSQI scores remained above the cutoff through the 5 year mark 
regardless of whether or not there was a resolution of fatigue. 
For both cohorts, depression was comparable at T1 with notable divergence at T2. This 
difference was only significant for the Y1-2 Cohort but the general trend of reduced depression 
was seen in the FR Groups. This is not surprising given the relationship between fatigue and 
depression and the item content on the PHQ-9 inquiring about tiredness and lack of energy.   
Like previous cross sectional research, these results show a relationship between the 
lingering of fatigue with increased disability, ongoing of sleep disturbance, and depression [7]. 
However, these findings look at these relationships from a longitudinal perspective to show that 
differences in fatigue from 1 to 2 years post injury appear to be associated with more change 
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over time than is seen in the other cohort at 2 to 5 years post-injury. This mirrors what is often 
observed in TBI recovery where accelerated recovery may be noted in the acute phase of 
rehabilitation with additional change being more asymptotic or at a slower rate [40, 41]. In 
addition, the relationship between fatigue and life satisfaction or functional independence found 
in cross-sectional studies were not found when looking at fatigue resolution over time. This may 
be due to the dichotomization into FR and FU groups as opposed to viewing MAF scores as a 
continuum in a correlational analysis. It may also be due to a restricted range in the current 
sample which only included individuals with PTBIF at their initial follow-up interview. 
Satisfaction with life remained stable over time in each group suggesting there may be factors 
other than the resolution of fatigue that may be influencing life satisfaction over time. 
At least two therapeutic alternatives can be proposed when an individual presents with 
PTBIF in order to resolve the fatigue as quickly as possible. The first would be to assess and 
address sleep dysfunction issues; in the group of individuals whose PTBIF resolved more 
acutely, the sleep quality also improved. Improving sleep quality may decrease PTBIF in a select 
group of individuals. For those persons whose PTBIF does not resolve after treating sleep 
dysfunction, assessment and treatment of concomitant depression may prove an effective 
management technique.  
Limitations 
Limitations of the current study should be noted to understand the findings in proper 
context. A ceiling effect on the FIM could be seen as a limitation inherent in the measure such 
that it lacks sensitivity in differentiating among individuals who are functioning at a higher level. 
In this respect, perhaps the FIM is more suitable for its most common use – the evaluation of 
functional status throughout the course of inpatient rehabilitation, as opposed to measurements 
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taken at one or more years after discharge. Another limitation was identified in the GFI 
generated using the MAF. Among those who showed remission of PTBIF at T2 based on the cut-
off score on the GFI, approximately half obtained scores of 0. It is important to point out that the 
first question on the MAF asks, “[Over the past week] To what degree have you experienced 
fatigue?” Possible responses range from 1 (not at all) to 10 (a great deal). For participants who 
responded “not at all,” the measure was discontinued and they received a GFI score of 0. This 
created a kurtotic distribution where the mode was 0 and the next highest value was 7.5 
However, by discontinuing the questionnaire at this point for those providing the lowest possible 
rating, a dichotomy is created whereby these individuals have less opportunity for variation 
because all receive a GFI of 0. Those scoring 2-10 on this initial item at T2 showed greater 
variability with GFI scores ranging from 7.5 to 20.9.  
It is also important to note that this study was limited to a select group of individuals who 
survived TBI and required inpatient rehabilitation. Thus, the findings may not represent all 
individuals with PTBIF. In addition, the Y1-2 Cohort and Y2-5 Cohort studied here were 
relatively small (N=47 and N=32, respectively). They represent a smaller portion of participants 
in the original larger study where the sample size was closer to 100 in each cohort. This was due 
to purposeful extraction of only those individuals with PTBIF at T1 in order to examine factors 
associated with remission of PTBIF. Further study on larger samples are needed to provide a 
better understanding of causal, mediating, and/or moderating factors with greater generalizability 
in order to develop effective interventions for PTBIF.  
In addition, self-report measures and retrospective assessment were used to 
characterize insomnia, fatigue and function which may be impacted by recall and self-awareness 
which may be particularly limited among individuals with TBI. 
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5.  Conclusion 
Less than half of the sample experienced a remission of PTBIF between time points. 
Persistence of fatigue appears to be related to level of disability and depression, underscoring the 
potential impact of effective surveillance, assessment, and treatment of this condition in 
optimizing quality of life after TBI.  Differences in fatigue progression may point to the presence 
of different types of PTBIF. 
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Table 1: Sample Demographics and Injury Characteristics by Cohort 
  
Cohort Y1-2 
(N=47)   
Cohort Y2-5 
(N=32) 
count %   count % 
Gender           
   Female 15 32% 8 25% 
   Male 32 68% 24 75% 
Race/ethnicity     
   Non-Hispanic White 28 60% 25 78% 
   Non-Hispanic Black 4 9% 1 3% 
   Hispanic 11 23% 5 16% 
   Other 4 9% 1 3% 
Marital Status     
   Single 20 43% 13 41% 
   Married 17 36% 12 37% 
   Divorced, Separated, Widowed 10 21% 7 22% 
Injury Severity     
   Moderate 31 66% 21 66% 
   Severe 16 34% 11 34% 
Cause of Injury     
   Vehicular 27 57% 22 69% 
   Fall 15 32% 4 13% 
   Assault 3 6% 3 9% 
   Sports or Other 2 4%    3 9% 
 
 
 
Table 2: Descriptive Statistics for Age, Education, and Hospitalization Variables by Cohort 
  
Cohort Y1-2 
(N=47)   
Cohort Y2-5 
(N=32) 
M SD   M SD 
Age at Injury 41.1 19.6 35.6 16.1 
Years of Education 13.0 2.9 12.3 2.2 
Days in Posttraumatic Amnesia 21.7 18.8 23.9 18.8 
Length of Stay in Acute Care 19.4 14.6 22.3 16.5 
Length of Stay in Rehabilitation 20.6 11 22.2 14.1 
FIM at Rehabilitation Admission 50.1 23.9 47.8 22.2 
FIM at Rehabilitation Discharge 94.5 15.8 99.3 14.6 
DRS at Rehabilitation Admission 11.1 5 12.4 4.6 
DRS at Rehabilitation Discharge 4.6 2    5.6 2.6 
 
FIM: Functional Independence Measure; DRS: Disability Rating Scale 
 
 
 
 
 
 
 
 
 
 
 
 




